Source record

Quantitative assist for immunohistochemistry scoring

ベンダー

この言語の本文は未訳のため、英語で表示しています。

The source is PathAI’s company website, dated in this index as 1 February 2025, read as a vendor description of algorithms that estimate immunohistochemistry staining. Ibex is named as another vendor in the same class. The page is not an independent concordance study. No percentage agreement is copied, because those figures are assay-specific and easy to over-read.

Source date: 2025年2月1日 · 年 2025
Evidence label: ベンダー報告
Source type: ベンダー

Citation

PathAI

PathAI. Company website, dated in this index as 1 February 2025. https://www.pathai.com/ Vendor description of pathology algorithms. Ibex is named only as another company offering quantitative immunohistochemistry assist. Not an independent assay study.

Key public facts

The cited page is a vendor website, not a peer-reviewed concordance study.
The workflow is an estimate of staining extent, such as Ki-67 or PD-L1, on a digitized slide that already has a clinical scoring scheme.
A pathologist checks the region and the number before the score enters the report.
The signed score remains a pathology result.
No concordance figure is copied. Vendor white papers stay vendor-reported until an independent study matches the assay in local use.

Original link

Opens the publisher page in a new tab.

Back to the case

教育と市場把握のための条目。医療助言でも推奨でもありません。